Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II SGI-110 trial begins in hepatocellular carcinoma

Jan. 3, 2013

TRU-016 receives orphan medicinal product designation in Europe for CLL

Jan. 3, 2013

Novel monoclonal antibodies divulged by Antitope

Jan. 3, 2013

Epizyme presents novel epigenetic-targeted, small-molecule anticancer agents

Jan. 3, 2013

Evotec and Apeiron Biologics establish cancer immunotherapy collaboration

Jan. 2, 2013

New compound demonstrates efficacy in KSHV-associated primary effusion lymphoma

Jan. 2, 2013

CT Atlantic and the Universitat Zurich patent novel antibodies for cancer

Jan. 2, 2013

AI-10-49 proves effective in murine leukemia model

Jan. 2, 2013

Targeting MALT1 as a therapeutic approach for ABC-DLBCL

Jan. 2, 2013

Special protocol assessment agreement reached for phase III AEZS-108 trial

Jan. 2, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...